Novo Nordisk
NVO
NVO
900 hedge funds and large institutions have $15.2B invested in Novo Nordisk in 2022 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 298 increasing their positions, 304 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
900
Holders Change
+17
Holders Change %
+1.93%
% of All Funds
14.24%
Holding in Top 10
23
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.36%
New
84
Increased
298
Reduced
304
Closed
60
Calls
$186M
Puts
$141M
Net Calls
+$45M
Net Calls Change
-$44M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$540M |
| 2 |
BlackRock
New York
|
+$175M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$64.9M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$60.7M |
| 5 |
VIP
Vantage Investment Partners
Kansas City,
Missouri
|
+$54.3M |
Top Sellers
| 1 |
ClearBridge Investments
New York
|
-$154M |
| 2 |
Renaissance Technologies
New York
|
-$81.4M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$36.6M |
| 4 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
-$35.5M |
| 5 |
Two Sigma Advisers
New York
|
-$32.3M |
